{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:49:30Z","timestamp":1791496170556,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,11,8]],"date-time":"2010-11-08T00:00:00Z","timestamp":1289174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1748-717x-5-104","type":"journal-article","created":{"date-parts":[[2010,11,9]],"date-time":"2010-11-09T02:14:46Z","timestamp":1289268886000},"source":"Crossref","is-referenced-by-count":187,"title":["Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome"],"prefix":"10.1186","volume":"5","author":[{"given":"Steve","family":"Heymann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzette","family":"Delaloge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arslane","family":"Rahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Frebourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Barreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Pachet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Marsiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Bourgier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,8]]},"reference":[{"key":"310_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.7326\/0003-4819-71-4-747","volume":"71","author":"FP LI","year":"1969","unstructured":"Li FP, Fraumeni JF Jr: Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med 1969, 71: 747-752.","journal-title":"Ann Intern Med"},{"key":"310_CR2","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1200\/JCO.2008.16.6959","volume":"27","author":"KD Gonzalez","year":"2009","unstructured":"Gonzalez KD, Noltner KA, Buzin CH, et al.: Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol 2009, 27: 1250-1256. 10.1200\/JCO.2008.16.6959","journal-title":"J Clin Oncol"},{"key":"310_CR3","first-page":"5358","volume":"48","author":"FP LI","year":"1988","unstructured":"Li FP, Fraumeni JF Jr, Mulvihill JJ, et al.: A cancer family syndrome in twenty-four kindreds. Cancer Res 1988, 48: 5358-5362.","journal-title":"Cancer Res"},{"key":"310_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/humu.10185","volume":"21","author":"JM Varley","year":"2003","unstructured":"Varley JM: Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mutat 2003, 21: 313-320. 10.1002\/humu.10185","journal-title":"Hum Mutat"},{"key":"310_CR5","first-page":"6643","volume":"63","author":"M Olivier","year":"2003","unstructured":"Olivier M, Goldgar DE, Sodha N, et al.: Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res 2003, 63: 6643-6650.","journal-title":"Cancer Res"},{"key":"310_CR6","first-page":"8062","volume":"61","author":"SB Lee","year":"2001","unstructured":"Lee SB, Kim SH, Bell DW, et al.: Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome. Cancer Res 2001, 61: 8062-8067.","journal-title":"Cancer Res"},{"key":"310_CR7","first-page":"117","volume":"222","author":"J Varley","year":"2003","unstructured":"Varley J: TP53, hChk2, and the Li-Fraumeni syndrome. Methods Mol Biol 2003, 222: 117-129.","journal-title":"Methods Mol Biol"},{"key":"310_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/bcr582","volume":"5","author":"J Varley","year":"2003","unstructured":"Varley J, Haber DA: Familial breast cancer and the hCHK2 1100delC mutation: assessing cancer risk. Breast Cancer Res 2003, 5: 123-125. 10.1186\/bcr582","journal-title":"Breast Cancer Res"},{"key":"310_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35042675","volume":"408","author":"B Vogelstein","year":"2000","unstructured":"Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. Nature 2000, 408: 307-310. 10.1038\/35042675","journal-title":"Nature"},{"key":"310_CR10","first-page":"47","volume":"1602","author":"KH Vousden","year":"2002","unstructured":"Vousden KH: Activation of the p53 tumor suppressor protein. Biochim Biophys Acta 2002, 1602: 47-59.","journal-title":"Biochim Biophys Acta"},{"key":"310_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/bcr426","volume":"4","author":"M Gasco","year":"2002","unstructured":"Gasco M, Shami S, Crook T: The p53 pathway in breast cancer. Breast Cancer Res 2002, 4: 70-76. 10.1186\/bcr426","journal-title":"Breast Cancer Res"},{"key":"310_CR12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1568-7864(03)00002-8","volume":"2","author":"QE Wang","year":"2003","unstructured":"Wang QE, Zhu Q, Wani MA, et al.: Tumor suppressor p53 dependent recruitment of nucleotide excision repair factors XPC and TFIIH to DNA damage. DNA Repair (Amst) 2003, 2: 483-499. 10.1016\/S1568-7864(03)00002-8","journal-title":"DNA Repair (Amst)"},{"key":"310_CR13","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.1038\/sj.onc.1206677","volume":"22","author":"P Fei","year":"2003","unstructured":"Fei P, El-Deiry WS: P53 and radiation responses. Oncogene 2003, 22: 5774-5783. 10.1038\/sj.onc.1206677","journal-title":"Oncogene"},{"key":"310_CR14","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/sj.onc.1206155","volume":"22","author":"G Bougeard","year":"2003","unstructured":"Bougeard G, Brugieres L, Chompret A, et al.: Screening for TP53 rearrangements in families with the Li-Fraumeni syndrome reveals a complete deletion of the TP53 gene. Oncogene 2003, 22: 840-846. 10.1038\/sj.onc.1206155","journal-title":"Oncogene"},{"key":"310_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0140-6736(97)01116-1","volume":"350","author":"SJ Kony","year":"1997","unstructured":"Kony SJ, de Vathaire F, Chompret A, et al.: Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet 1997, 350: 91-95. 10.1016\/S0140-6736(97)01116-1","journal-title":"Lancet"},{"key":"310_CR16","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/jnci\/90.8.606","volume":"90","author":"M Hisada","year":"1998","unstructured":"Hisada M, Garber JE, Fung CY, et al.: Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst 1998, 90: 606-611. 10.1093\/jnci\/90.8.606","journal-title":"J Natl Cancer Inst"},{"key":"310_CR17","first-page":"300","volume":"12","author":"C Nutting","year":"2000","unstructured":"Nutting C, Camplejohn RS, Gilchrist R, et al.: A patient with 17 primary tumours and a germ line mutation in TP53: tumour induction by adjuvant therapy? Clin Oncol (R Coll Radiol) 2000, 12: 300-304.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"310_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/ijc.1021","volume":"96","author":"JM Limacher","year":"2001","unstructured":"Limacher JM, Frebourg T, Natarajan-Ame S, et al.: Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndrome. Int J Cancer 2001, 96: 238-242. 10.1002\/ijc.1021","journal-title":"Int J Cancer"},{"key":"310_CR19","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.clon.2007.05.001","volume":"19","author":"A Salmon","year":"2007","unstructured":"Salmon A, Amikam D, Sodha N, et al.: Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation. Clin Oncol (R Coll Radiol) 2007, 19: 490-493.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"310_CR20","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.radonc.2007.01.001","volume":"82","author":"MA Bollet","year":"2007","unstructured":"Bollet MA, Sigal-Zafrani B, Mazeau V, et al.: Age remains the first prognostic factor for loco-regional breast cancer recurrence in young ( < 40 years) women treated with breast conserving surgery first. Radiother Oncol 2007, 82: 272-280. 10.1016\/j.radonc.2007.01.001","journal-title":"Radiother Oncol"},{"key":"310_CR21","doi-asserted-by":"crossref","unstructured":"Prise en charge du cancer du sein infiltrant de la femme non m\u00e9nopaus\u00e9e Oncologie 2009, 11: 507-532. 10.1007\/s10269-009-1818-6","DOI":"10.1007\/s10269-009-1818-6"},{"key":"310_CR22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/modpathol.3800528","volume":"19","author":"CA Livasy","year":"2006","unstructured":"Livasy CA, Karaca G, Nanda R, et al.: Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol 2006, 19: 264-271. 10.1038\/modpathol.3800528","journal-title":"Mod Pathol"},{"key":"310_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/jnci\/87.1.19","volume":"87","author":"U Veronesi","year":"1995","unstructured":"Veronesi U, Marubini E, Del Vecchio M, et al.: Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 1995, 87: 19-27. 10.1093\/jnci\/87.1.19","journal-title":"J Natl Cancer Inst"},{"key":"310_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0360-3016(94)90515-0","volume":"30","author":"BL Fowble","year":"1994","unstructured":"Fowble BL, Schultz DJ, Overmoyer B, et al.: The influence of young age on outcome in early stage breast cancer. Int J Radiat Oncol Biol Phys 1994, 30: 23-33.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"310_CR25","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/sj.bjc.6601138","volume":"89","author":"C Rubino","year":"2003","unstructured":"Rubino C, de Vathaire F, Shamsaldin A, et al.: Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment. Br J Cancer 2003, 89: 840-846. 10.1038\/sj.bjc.6601138","journal-title":"Br J Cancer"},{"key":"310_CR26","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1038\/sj.onc.1201050","volume":"14","author":"D Delia","year":"1997","unstructured":"Delia D, Goi K, Mizutani S, et al.: Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations. Oncogene 1997, 14: 2137-2147. 10.1038\/sj.onc.1201050","journal-title":"Oncogene"},{"key":"310_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1667\/RR3190","volume":"162","author":"RE Mitchel","year":"2004","unstructured":"Mitchel RE, Jackson JS, Carlisle SM: Upper dose thresholds for radiation-induced adaptive response against cancer in high-dose-exposed, cancer-prone, radiation-sensitive Trp53 heterozygous mice. Radiat Res 2004, 162: 20-30. 10.1667\/RR3190","journal-title":"Radiat Res"},{"key":"310_CR28","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1200\/JCO.2009.22.7967","volume":"27","author":"J Tinat","year":"2009","unstructured":"Tinat J, Bougeard G, Baert-Desurmont S, et al.: 2009 version of the Chompret criteria for Li Fraumeni syndrome. J Clin Oncol 2009, 27: e108-109. author reply e110 10.1200\/JCO.2009.22.7967","journal-title":"J Clin Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-5-104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1748-717X-5-104\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-5-104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T23:44:20Z","timestamp":1548200660000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-5-104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,8]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["310"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-5-104","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,8]]},"article-number":"104"}}